Literature DB >> 21061035

Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.

N Miyashita1, Y Kawai, T Yamaguchi, K Ouchi, M Oka.   

Abstract

The purpose of the present study was to evaluate the accuracy and usefulness of three rapid diagnostic methods, ImmunoCard Mycoplasma kit, chest high-resolution computed tomography (HRCT) findings, and the Japanese Respiratory Society (JRS) scoring system (including six parameters), for the early presumptive diagnosis of Mycoplasma pneumoniae pneumonia in adults. We performed three rapid diagnostic methods at the same time in four pneumonia groups: 68 cases with M. pneumoniae pneumonia, 133 cases with Streptococcus pneumoniae pneumonia, 30 cases with Haemophilus influenzae pneumonia, and 20 cases with Legionella pneumonia. The sensitivity and specificity were 35% and 68% for ImmunoCard, 73% and 85% with HRCT, and 83% and 90% with the JRS scoring system, respectively. Among the three rapid diagnostic methods, the JRS scoring system was the most useful tool for initiating the administration of adequate antibiotic therapy for probable M. pneumoniae pneumonia. We suggest that M. pneumoniae pneumonia should be suspected when there is a correlation of more than five parameters in the JRS scoring system (99% specificity). If there is a correlation of three or four parameters in the JRS scoring system, chest computed tomography (CT) findings are helpful for the presumptive diagnosis of M. pneumoniae pneumonia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061035     DOI: 10.1007/s10096-010-1107-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Clinical differentiation of atypical pneumonia using Japanese guidelines.

Authors:  Tadashi Ishida; Naoyuki Miyashita; Chikara Nakahama
Journal:  Respirology       Date:  2007-01       Impact factor: 6.424

2.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

Authors:  B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

3.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

4.  Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen.

Authors:  J A Ramirez; S Ahkee; A Tolentino; R D Miller; J T Summersgill
Journal:  Diagn Microbiol Infect Dis       Date:  1996-01       Impact factor: 2.803

5.  Is it possible to distinguish between atypical pneumonia and bacterial pneumonia?: evaluation of the guidelines for community-acquired pneumonia in Japan.

Authors:  Naoyuki Miyashita; Hiroshi Fukano; Koichiro Yoshida; Yoshihito Niki; Toshiharu Matsushima
Journal:  Respir Med       Date:  2004-10       Impact factor: 3.415

6.  Mycoplasma pneumoniae pneumonia in the elderly.

Authors:  Naoyuki Miyashita; Kazunobu Ouchi; Kozo Kawasaki; Keiko Oda; Yasuhiro Kawai; Hiroki Shimizu; Yoshihiro Kobashi; Mikio Oka
Journal:  Med Sci Monit       Date:  2008-08

Review 7.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.

Authors:  Miyuki Morozumi; Takashi Takahashi; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2010-01-22       Impact factor: 2.211

8.  Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates.

Authors:  Takao Ozaki; Naoko Nishimura; Jaekun Ahn; Naoko Watanabe; Taichiro Muto; Akiko Saito; Norio Koyama; Kazumasa Nakane; Keiji Funahashi
Journal:  J Infect Chemother       Date:  2007-08-27       Impact factor: 2.211

9.  [Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan].

Authors:  Shin-ichi Yokota; Kiyoshi Sato; Shigeru Yoshida; Nobuhiro Fujii
Journal:  Kansenshogaku Zasshi       Date:  2004-05

10.  Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.

Authors:  Naoyuki Miyashita; Tadaaki Sugiu; Yasuhiro Kawai; Keiko Oda; Tetsuya Yamaguchi; Kazunobu Ouchi; Yoshihiro Kobashi; Mikio Oka
Journal:  BMC Med Imaging       Date:  2009-04-29       Impact factor: 1.930

View more
  13 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

3.  Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Tokio Wakabayashi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

4.  Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Kazunobu Ouchi; Niro Okimoto
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

5.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Authors:  Naoyuki Miyashita; Yasuhiro Kawai; Hiroto Akaike; Kazunobu Ouchi; Toshikiyo Hayashi; Takeyuki Kurihara; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

6.  Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.

Authors:  Takaaki Tanaka; Tomohiro Oishi; Ippei Miyata; Shoko Wakabayashi; Mina Kono; Sahoko Ono; Atsushi Kato; Yoko Fukuda; Aki Saito; Eisuke Kondo; Hideto Teranishi; Yuhei Tanaka; Tokio Wakabayashi; Hiroto Akaike; Satoko Ogita; Naoki Ohno; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

7.  Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.

Authors:  Linlin Zhang; Diane C Wang; Qihong Huang; Xiangdong Wang
Journal:  Clin Transl Med       Date:  2020-04-04

8.  Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Yasuhiro Kawai; Kazunobu Ouchi; Tadashi Kato; Toshikiyo Hayashi; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2013-03-11       Impact factor: 3.090

Review 9.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

10.  Clinical Application of High-Resolution Computed Tomographic Imaging Features of Community-Acquired Pneumonia.

Authors:  Yunqiang Nie; Cuiyun Li; Jingling Zhang; Hui Wang; Ping Han; Xin Lv; Xinyi Xu; Miao Guo
Journal:  Med Sci Monit       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.